Delivery Order SPE2DB20D2104-SPE2DB24FV16V

Award Date 7/12/24
Potential Completion Date 7/15/24
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is valued at $2,949.01 and was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, as a delivery order. The contract is for the supply of 4,565,860,584 units of Ciprofloxacin HCL 250 MG tablets, a generic antibiotic medication. The contract has a firm fixed price and an ultimate completion date of September 19, 2024. This award is not associated with a set-aside program. AmerisourceBergen holds significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,557,612,521 units of Ciprofloxacin HCL 250 mg tablets. The $6,184.04 firm fixed-price delivery order has a completion date of June 23, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
This federal contract award is for the delivery of 4,558,280,789 units of Ciprofloxacin HCL 250 mg tablets to the Defense Logistics Agency (DLA). The $1,032.68 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 30, 2022, with an ultimate completion date of August 31, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle...
This federal contract award, valued at $1,846.67, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of 4,562,315,808 units of the drug Ciprofloxacin HCL 500 mg Tablets, which are used to treat a variety of bacterial infections. The contract has a completion date of September 27, 2023 and utilizes a Firm Fixed Price pricing type. This is a delivery order...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,565,221,038 units of Ciprofloxacin HCL 500 mg tablets. The delivery order has a ceiling value of $3,243.16 and a performance period ending on July 24, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,436.59 firm-fixed-price delivery order is for the supply of 4,562,923,060 units of Ciprofloxacin HCL 750 mg tablets. The award has an ultimate completion date of November 29, 2023 and is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award issued by the Defense Logistics Agency (DLA) is a delivery order valued at $4,609.20 and awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4,562,248,373 units of Ciprofloxacin HCL 500 mg tablets and has a completion date of September 21, 2023. The contract is a firm fixed-price delivery order and was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, valued at $4,262.57, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for 4,565,659,772 units of Ciprofloxacin HCL 250 mg tablets, with an ultimate completion date of September 4, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,880.26 delivery order is for the supply of 4,555,324,146 units of Ciprofloxacin HCL 500 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of November 5, 2021. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,017.84, is a delivery order for the supply of 4,567,074,482 units of Ciprofloxacin HCL 250 mg tablets. The contract has an ultimate completion date of January 29, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FV16V
    Delivery Order

The federal contract award, valued at $2,274.75, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the delivery of 4,565,134,472 units of Ciprofloxacin HCL 500 mg tablets. This is a firm-fixed-price delivery order contract with a period of performance through July 15, 2024. The contract is not designated as a set-aside and was likely awarded through open competition. AmerisourceBergen, a major pharmaceutical distributor, has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 9:59 AM